BioLife Solutions (BLFS)
(Delayed Data from NSDQ)
$21.52 USD
+1.22 (6.01%)
Updated Jun 10, 2024 04:00 PM ET
After-Market: $21.49 -0.03 (-0.14%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum D VGM
Brokerage Reports
0 items in cart
BioLife Solutions, Inc. [BLFS]
Reports for Purchase
Showing records 21 - 40 ( 91 total )
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Cell Therapy Market Arrives; Margins Next; FY22-25 Could Show Compelling Combination
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
3Q22 Debunks Cell & Gene Therapy Market Concerns
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
All-Around Surprise from Cell Media and Stirling in 2Q
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Cell Processing Up 67%; Stirling Improves
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Bioproduction: Tool Shares Weak but More Cell Therapy Catalysts
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
2022 Life Sciences and MedTech Conference: Day 2 Takeaways
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Cell & Gene Therapy Growth Drives Top-Line Beat
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Management Changes at CFO and President; Earnings on November 11th
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Company: BioLife Solutions, Inc.
Industry: Medical - Products
Life Science Tools: Industry Tailwind of Record FDA Approvals Likely Growing Stronger
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department